{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:42:23Z","timestamp":1790401343957,"version":"4.1.0"},"reference-count":24,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,4]]},"DOI":"10.26633\/rpsp.2024.129","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:55:59Z","timestamp":1733316959000},"page":"1","source":"Crossref","is-referenced-by-count":4,"title":["Impact of prior dengue infection on severity and outcomes: meta-analysis of placebo-controlled trials"],"prefix":"10.26633","volume":"48","author":[{"given":"Alejandro","family":"Macchia","sequence":"first","affiliation":[{"name":"https:\/\/orcid.org\/0000-0002-5424-5009"},{"name":"Subsecretar\u00eda de Planificaci\u00f3n Sanitaria, Ministerio de Salud de la Ciudad de Buenos Aires, Ciudad Aut\u00f3noma de Buenos Aires, Argentina"},{"name":"amacchia@buenosaires.gob.ar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Figar","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0001-7131-5761"},{"name":"\u00c1rea de Investigaci\u00f3n en Salud Poblacional de la Secretar\u00eda de Investigaci\u00f3n de la Universidad Hospital Italiano de Buenos Aires, Global Epidemiology-IMTIB-CONICET, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Biscayart","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0003-1319-5022"},{"name":"Gerencia Operativa de Epidemiolog\u00eda, Ministerio de Salud de la Ciudad de Buenos Aires, Ciudad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern\u00e1n","family":"Gonz\u00e1lez Bernaldo de Quir\u00f3s","sequence":"additional","affiliation":[{"name":"https:\/\/orcid.org\/0000-0002-9052-6684"},{"name":"Ministerio de Salud de la Ciudad Aut\u00f3noma de Buenos Aires, Ciudad Aut\u00f3noma de Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16:712-23.","DOI":"10.1016\/S1473-3099(16)00026-8"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Zeng Z, Zhan J, Chen L, Chen H, Cheng S. Global, regional, and national dengue burden from 1990 to 2017: a systematic analysis based on the Global Burden of Disease Study 2017. EClinicalMedicine 2021;32:100712.","DOI":"10.1016\/j.eclinm.2020.100712"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Yuan K, Chen Y, Zhong M, Lin Y, Liu L. Risk and predictive factors for severe dengue infection: a systematic review and meta-analysis. PLoS One. 2022;17:e0267186.","DOI":"10.1371\/journal.pone.0267186"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Huy NT, Van Giang T, Thuy DH, Kikuchi M, Hien TT, Zamora J, Hirayama K. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7:e2412.","DOI":"10.1371\/journal.pntd.0002412"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, et al. Failure of secondary infection with American geno\u00adtype dengue 2 to cause dengue haemorrhagic fever. Lancet. 1999;354:1431-34.","DOI":"10.1016\/S0140-6736(99)04015-5"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, et al. Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis. 2013;208:1026-33.","DOI":"10.1093\/infdis\/jit273"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158:1445-59.","DOI":"10.1007\/s00705-013-1645-3"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Kall\u00e1s EG, Cintra MAT, Moreira JA, Pati\u00f1o EG, Braga PE, Ten\u00f3rio JCV, et al. Live, attenuated, tetravalent Butantan\u2013dengue vaccine in children and adults. N Engl J Med. 2024;390:397-408.","DOI":"10.1056\/NEJMoa2301790"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Tricou V, Yu D, Reynales H, Biswal S, Saez-Llorens X, Sirivichayakul C, et al. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2024;12:e257-70.","DOI":"10.1016\/S2214-109X(23)00522-3"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384:1358-65.","DOI":"10.1016\/S0140-6736(14)61060-6"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Villar L, Dayan GH, Arredondo-Garc\u00eda JL, Rivera DM, Cunha R, Deseda C, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2015;372:113-23.","DOI":"10.1056\/NEJMoa1411037"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Forrat R, Dayan GH, DiazGranados CA, Bonaparte M, Laot T, Capeding MR, et al. Analysis of hospitalized and severe dengue cases over the 6 years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America. Clin Infect Dis. 2021;73:1003-12.","DOI":"10.1093\/cid\/ciab288"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kliks S, Nisalak A, Brandt W, Wahl L, Burke D. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40:444-51.","DOI":"10.4269\/ajtmh.1989.40.444"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr. 2014;2:10.1128\/microbiolspec.aid-0022-2014.","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Silva N, Undurraga E, Ferreira E, Estofolete C, Nogueira M. Clinical, laboratory, and demographic determinants of hospitalization due to dengue in 7613 patients: a retrospective study based on hierarchical models. Acta Trop. 2018;177:25-31.","DOI":"10.1016\/j.actatropica.2017.09.025"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Aggarwal C, Ahmed H, Sharma P, Reddy ES, Nayak K, Singla M, et al. Severe disease during both primary and secondary dengue virus infections in pediatric populations. Nat Med. 2024;30:670\u201374.","DOI":"10.1038\/s41591-024-02798-x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Sangkaew S, Ming D, Boonyasiri A, Honeyford K, Kalayanarooj S, Yacoub S, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21:1014-26.","DOI":"10.1016\/S1473-3099(20)30601-0"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Guzm\u00e1n MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118-24.","DOI":"10.1016\/S1201-9712(02)90072-X"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Horstick O, Farrar J, Lum L, Mart\u00ednez E, Martin J, Ehrenberg J, et al. Reviewing the development, evidence base, and application of the revised dengue case classification. Pathog Glob Health. 2012;106:94-101.","DOI":"10.1179\/2047773212Y.0000000017"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Horstick O, Jaenisch T, Mart\u00ednez E, Kroeger A, See L, Farrar J, Ranzinger S. Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review. Am J Trop Med Hyg. 2014;91:621-34.","DOI":"10.4269\/ajtmh.13-0676"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Narvaez F, Gutierrez G, P\u00e9rez MA, Elizondo D, Nu\u00f1ez A, Balmaseda A, et al. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis. 2011;5:e1397.","DOI":"10.1371\/journal.pntd.0001397"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Halstead SB. Three dengue vaccines \u2013 what now? N Engl J Med. 2024;390:464-65.","DOI":"10.1056\/NEJMe2314240"},{"key":"ref23","unstructured":"World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization; 1997. https:\/\/iris.who.int\/handle\/10665\/41988"},{"key":"ref24","unstructured":"World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control, new edition. Geneva: World Health Organization; 2009. https:\/\/iris.who.int\/handle\/10665\/44188"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/62661\/v48e1292024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:56:12Z","timestamp":1733316972000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/62661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":24,"alternative-id":["RPSP.2024.129"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2024.129","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]}}}